Source: The FASEB Journal. Unidade: ICB
Assunto: IMUNOLOGIA
ABNT
FELIZARDO, Raphael José Ferreira et al. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic‐ and GPR109a‐mediated mechanisms. The FASEB Journal, v. 33, n. 11, p. 11894-11908, 2019Tradução . . Disponível em: https://doi.org/10.1096/fj.201901080R. Acesso em: 31 ago. 2024.APA
Felizardo, R. J. F., Almeida, D. C. de, Pereira, R. L., Watanabe, I. K. M., Doimo, N. T. dos S., Ribeiro, W. R., et al. (2019). Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic‐ and GPR109a‐mediated mechanisms. The FASEB Journal, 33( 11), 11894-11908. doi:10.1096/fj.201901080RNLM
Felizardo RJF, Almeida DC de, Pereira RL, Watanabe IKM, Doimo NT dos S, Ribeiro WR, Cenedeze MA, Hiyane MI, Amano MT, Braga TT, Ferreira CM, Parmigiani RB, Oliveira V de A, Volpini RA, Vinolo MAR, Moreno EM, Robert R, Mackay CR, Câmara NOS. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic‐ and GPR109a‐mediated mechanisms [Internet]. The FASEB Journal. 2019 ; 33( 11): 11894-11908.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1096/fj.201901080RVancouver
Felizardo RJF, Almeida DC de, Pereira RL, Watanabe IKM, Doimo NT dos S, Ribeiro WR, Cenedeze MA, Hiyane MI, Amano MT, Braga TT, Ferreira CM, Parmigiani RB, Oliveira V de A, Volpini RA, Vinolo MAR, Moreno EM, Robert R, Mackay CR, Câmara NOS. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic‐ and GPR109a‐mediated mechanisms [Internet]. The FASEB Journal. 2019 ; 33( 11): 11894-11908.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1096/fj.201901080R